Hepatitis B vaccine (recombinant) 10mcg/0.5mL, 20mcg/mL; susp; aluminum hydroxide adsorbed; IM inj; preservative-free. Infection with hepatitis B virus can have serious consequences including ...
Trials with Heplisav were halted last month in response to a serious adverse effect report from a phase 3 trial comparing Heplisav to a marketed hepatitis B vaccine, Engerix-B, sold by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback